{"title":"Enavant","description":"\u003cp\u003eShop Enavant pet medicines \u0026amp; care online in India at Paws \u0026amp; Tails™. Browse the available listings together and compare the exact product, format and pack size before placing your order.\u003c\/p\u003e\u003ch2\u003eExplore the Enavant range\u003c\/h2\u003e\u003cp\u003eProducts in this collection include:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eEnavant Boul K9 Muscle Builder for Dogs - 10 Capsules\u003c\/li\u003e\n\u003cli\u003eEnavant LAFK9 Hepatoprotective Liver Support Tablet for Dogs - 10 \/ 30 \/ 50 Tablets\u003c\/li\u003e\n\u003cli\u003eEnavant BOULK9 Capsules 250mg for Dogs \u0026amp; Cats\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eChoose the right product\u003c\/h2\u003e\u003cp\u003eOpen each listing for its stated ingredients or materials, intended use, available options and current price. Check species, life stage and size or weight requirements wherever applicable. Different products and strengths are not automatically interchangeable.\u003c\/p\u003e\u003cp\u003eFor medicines and specialist nutritional products, follow your veterinarian’s advice and the supplied label directions. Product-specific payment, delivery and handling conditions continue to apply.\u003c\/p\u003e","products":[{"product_id":"enavant-boul-k9-capsules-dogs-muscle-builder-strength-performance","title":"Enavant Boul K9 Muscle Builder for Dogs - 10 Capsules","description":"\u003cp\u003e\u003cstrong\u003eFor veterinary use. Administer as directed by a licensed veterinarian. Keep out of reach of children. Store in a cool, dry place away from direct sunlight. This supplement supports muscle development and physical performance in dogs under appropriate exercise and nutritional management — it is not a substitute for a balanced diet and veterinary care.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eEnavant Boul K9 Muscle Builder Strength \u0026amp; Performance Supplement Capsules for Dogs (10 Capsules)\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003eEnavant Boul K9 is a veterinary nutritional supplement capsule formulated to support lean muscle building, strength, stamina, endurance, and physical performance in active, athletic, working, and sporting dogs. Designed to promote muscular development, support exercise recovery, and maintain muscle mass in high-performance and working breed dogs. Also contains prebiotic and probiotic support for digestive health. Confirm exact active ingredient composition, amino acid and nutrient concentrations per capsule, probiotic strain(s) and CFU count, and prebiotic actives from the Enavant Boul K9 product label.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eComposition (confirm from product label)\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eMuscle-building nutritional actives — confirm specific active ingredients and concentrations per capsule from the Enavant Boul K9 product label; commonly expected actives in canine muscle builder supplements include amino acids and anabolic-supportive nutrients such as L-Carnitine (supports fat metabolism and energy utilisation during exercise), Branched-Chain Amino Acids — BCAAs (Leucine, Isoleucine, Valine — support muscle protein synthesis and recovery), L-Glutamine (supports muscle recovery and gut integrity), Creatine (supports ATP regeneration for short-burst muscular effort), and\/or other performance-supportive amino acids or nutritional actives — confirm actual composition from label\u003c\/li\u003e\n\u003cli\u003ePrebiotic actives — confirm specific prebiotic fibre(s) and concentration from label\u003c\/li\u003e\n\u003cli\u003eProbiotic strain(s) — confirm specific bacterial strain(s) and CFU count from label\u003c\/li\u003e\n\u003cli\u003eCapsule excipients — confirm from label\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eTherapeutic Class\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\u003cli\u003eVeterinary nutritional supplement capsule for dogs — lean muscle builder, strength, stamina, endurance, performance, and muscle recovery support for active, athletic, working, and sporting dogs; with prebiotic and probiotic digestive support\u003c\/li\u003e\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eKey Benefits\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eLean muscle building and development — amino acid actives support skeletal muscle protein synthesis, promoting lean muscle mass development in active and working dogs under appropriate exercise and nutritional management\u003c\/li\u003e\n\u003cli\u003eStrength and physical endurance — nutritional actives support muscular strength, physical endurance, and sustained performance capacity in working and sporting breeds during training and competition\u003c\/li\u003e\n\u003cli\u003eStamina support — performance-supportive actives help maintain energy substrate availability and delay muscular fatigue during prolonged physical activity\u003c\/li\u003e\n\u003cli\u003eMuscle recovery — post-exercise muscle recovery support; amino acid actives reduce muscle protein catabolism and support repair of exercise-induced micro-damage to muscle fibres\u003c\/li\u003e\n\u003cli\u003ePrebiotic and probiotic digestive support — prebiotic and probiotic actives support intestinal microbiome balance, gut motility, and digestive health, contributing to optimal nutrient absorption for performance nutrition\u003c\/li\u003e\n\u003cli\u003eMuscle mass maintenance — supports maintenance of muscle mass in dogs with muscle weakness, fatigue, or during recovery from illness or debility\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eIndications\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eActive, working, and sporting dogs requiring nutritional support for muscle development and physical performance\u003c\/li\u003e\n\u003cli\u003eHigh-performance and working breeds in training or competition\u003c\/li\u003e\n\u003cli\u003eDogs recovering from muscle weakness, fatigue, or debility\u003c\/li\u003e\n\u003cli\u003eDogs requiring nutritional support for lean muscle mass maintenance\u003c\/li\u003e\n\u003cli\u003eDogs with suboptimal digestive health requiring concurrent prebiotic and probiotic support\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eDirections for Use\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eAdminister orally as directed by a licensed veterinarian\u003c\/li\u003e\n\u003cli\u003eDosage is based on body weight and physical condition — confirm weight-based dose from the Enavant Boul K9 product label or veterinary prescription\u003c\/li\u003e\n\u003cli\u003eCapsules can be administered directly or the contents opened and mixed with food\u003c\/li\u003e\n\u003cli\u003eFor best results, use as part of an appropriate exercise and performance nutrition programme under veterinary guidance\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eSafety Information\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eFor veterinary use only — administer under veterinary guidance\u003c\/li\u003e\n\u003cli\u003eConfirm suitability for age and breed from product label before use; confirm minimum age from label before use in young or growing puppies\u003c\/li\u003e\n\u003cli\u003eConfirm suitability for pregnant, lactating, or breeding dogs from product label or veterinarian before use\u003c\/li\u003e\n\u003cli\u003eDiscontinue if any adverse reaction (gastrointestinal upset, vomiting, diarrhoea, behavioural change) is observed; consult a veterinarian\u003c\/li\u003e\n\u003cli\u003eKeep out of reach of children; store in a cool, dry place away from direct sunlight\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"Default Title","offer_id":46608196698287,"sku":"59688627","price":435.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/ChatGPTImageSep6_2026_01_38_16PM.png?v=1788682108"},{"product_id":"enavant-lafk9-dog-supplement-for-dogs-cats-1-strip","title":"Enavant LAFK9 Hepatoprotective Liver Support Tablet for Dogs - 10 \/ 30 \/ 50 Tablets","description":"\u003ch3\u003e\u003cstrong\u003eEnavant LAFK9 Hepatoprotective Liver Support Tablet for Dogs (10 \/ 30 \/ 50 Tablets)\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003eEnavant LAFK9 is a veterinary hepatoprotective liver support supplement formulated specifically for dogs. Designed to promote optimal liver function, support liver cell regeneration, aid detoxification, and improve appetite and digestion in dogs experiencing liver stress, hepatic toxicity, or recovering from liver disorders.\u003c\/p\u003e\u003cp\u003eAvailable in three convenient pack sizes — \u003cstrong\u003e1 Strip (10 Tablets)\u003c\/strong\u003e, \u003cstrong\u003e3 Strips (30 Tablets)\u003c\/strong\u003e, and \u003cstrong\u003e5 Strips (50 Tablets)\u003c\/strong\u003e — for flexible short-term and long-term use.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eNote:\u003c\/strong\u003e Please verify the exact active ingredient composition on the product label (formulation typically contains hepatoprotective agents such as Silymarin, SAMe, or similar liver-protective compounds; confirm with the product insert or your veterinarian).\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eKey Benefits\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eHepatoprotective — protects liver cells from toxin-induced and drug-induced damage\u003c\/li\u003e\n\u003cli\u003ePromotes liver cell regeneration and restoration of healthy hepatic tissue\u003c\/li\u003e\n\u003cli\u003eSupports natural liver detoxification and metabolic processes\u003c\/li\u003e\n\u003cli\u003eReduces oxidative stress on liver cells\u003c\/li\u003e\n\u003cli\u003eEnhances bile production for improved digestion and fat metabolism\u003c\/li\u003e\n\u003cli\u003eImproves appetite and nutrient absorption in dogs with liver conditions\u003c\/li\u003e\n\u003cli\u003eSuitable for dogs under long-term medication or with diagnosed hepatic disorders\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eIndications\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eLiver stress and hepatic toxicity in dogs\u003c\/li\u003e\n\u003cli\u003eFatty liver and hepatic lipidosis\u003c\/li\u003e\n\u003cli\u003eDrug-induced or toxin-induced liver damage\u003c\/li\u003e\n\u003cli\u003eHepatitis and liver cell damage\u003c\/li\u003e\n\u003cli\u003eRecovery from liver disorders or post-surgical hepatic support\u003c\/li\u003e\n\u003cli\u003eSupportive care during long-term antibiotic, steroid, or NSAID therapy\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eDosage \u0026amp; Administration\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eAdminister orally as directed by a veterinarian based on dog’s weight and condition\u003c\/li\u003e\n\u003cli\u003eCan be given directly or hidden in food\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eSafety Information\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eFor dogs only — veterinary use under professional supervision\u003c\/li\u003e\n\u003cli\u003eKeep out of reach of children\u003c\/li\u003e\n\u003cli\u003eStore in a cool, dry place away from direct sunlight\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"1 Strip 10 Tabs","offer_id":47215383904431,"sku":null,"price":415.0,"currency_code":"INR","in_stock":true},{"title":"3 Strips 30 Tabs","offer_id":47215383937199,"sku":null,"price":1249.29,"currency_code":"INR","in_stock":true},{"title":"5 Strips 50 Tabs","offer_id":47215383969967,"sku":null,"price":2080.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/ChatGPTImageJun7_2026_08_22_36PM.png?v=1780843998"},{"product_id":"enavant-boulk9-capsules-250mg-for-dogs-cats","title":"Enavant BOULK9 Capsules 250mg for Dogs \u0026 Cats","description":"\u003cp\u003e\u003cstrong\u003eEnavant BOULK9 Capsules 250mg for Dogs \u0026amp; Cats\u003c\/strong\u003e\u003cbr\u003e\u003cem\u003eAdvanced Probiotic Support with Saccharomyces Boulardii\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eSupport your pet’s digestive health with \u003cstrong\u003eEnavant BOULK9 Capsules\u003c\/strong\u003e, a high-quality veterinary probiotic formulated with \u003cstrong\u003eSaccharomyces boulardii\u003c\/strong\u003e. Designed for both dogs and cats, this advanced supplement helps maintain a healthy gut microbiome, improve digestion, and support overall immunity.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKey Benefits:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePromotes Digestive Health:\u003c\/strong\u003e Helps restore natural gut flora and supports optimal digestion in pets.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eEffective Diarrhea Support:\u003c\/strong\u003e Aids in managing loose stools caused by infections, antibiotics, or dietary changes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eBoosts Gut Microbiome:\u003c\/strong\u003e Contains Saccharomyces boulardii, a clinically trusted probiotic yeast that supports intestinal balance.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSupports Immune Function:\u003c\/strong\u003e Enhances natural defense mechanisms through improved gut health.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSuitable for Dogs \u0026amp; Cats:\u003c\/strong\u003e Safe and effective for daily use across breeds and sizes (as directed by a veterinarian).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWhy Choose BOULK9?\u003c\/strong\u003e\u003cbr\u003eUnlike standard probiotics, Saccharomyces boulardii is a resilient, non-pathogenic yeast that remains active even during antibiotic therapy, making it highly effective in maintaining gut stability and recovery.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eComposition:\u003c\/strong\u003e\u003cbr\u003eEach capsule contains:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eSaccharomyces boulardii – 250 mg (5 Billion CFU)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003cbr\u003eAdminister as advised by your veterinarian. Capsules can be given directly or mixed with food for easy consumption.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIdeal For:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eDigestive imbalance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eDiarrhea and loose stools\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ePost-antibiotic gut recovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGeneral gut health and immunity support\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePackaging:\u003c\/strong\u003e\u003cbr\u003eAvailable in a convenient pack of 10 capsules.\u003c\/p\u003e\n\u003cp\u003eGive your pets the digestive care they deserve with \u003cstrong\u003eEnavant BOULK9\u003c\/strong\u003e—trusted probiotic support for a healthier, happier life.\u003c\/p\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"Default Title","offer_id":47013943083183,"sku":null,"price":385.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/ChatGPTImageJun8_2026_06_30_34PM.png?v=1780923654"},{"product_id":"enavant-tumk9-capsules-for-dogs-cats-10-capsules","title":"Enavant TUMK9 Probiotic Capsules for Dogs \u0026 Cats - Strip of 10 Capsules","description":"\u003cp\u003e\u003cstrong\u003eEnavant TUMK9\u003c\/strong\u003e is a clinically validated, veterinary-grade probiotic supplement specifically designed to support kidney health in dogs and cats. Each capsule contains \u003cstrong\u003e90 Billion CFU\u003c\/strong\u003e of therapeutic microbes — Streptococcus Thermophilus, Lactobacillus Acidophilus, and Bifidobacterium Longum — that colonize the gut and actively metabolize uremic toxins, reducing the burden on compromised kidneys.\u003c\/p\u003e\u003ch3\u003eHow TUMK9 Works\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eTherapeutic probiotic microbes target and metabolize \u003cstrong\u003euremic nitrogenous waste\u003c\/strong\u003e as nutrients for their own growth\u003c\/li\u003e\n\u003cli\u003eAs microbes grow and multiply, they consume more nitrogenous waste, helping maintain healthy kidney function\u003c\/li\u003e\n\u003cli\u003eMetabolized toxins are eliminated from the body as solid waste through the bowel, relieving stress on the kidneys\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh CFU Count (90 Billion CFU)\u003c\/strong\u003e per capsule ensures superior potency and efficacy\u003c\/li\u003e\n\u003cli\u003eRestores balance of the \u003cstrong\u003egut microbiome\u003c\/strong\u003e for overall digestive and systemic health\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eKey Features\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eStreptococcus Thermophilus + Lactobacillus Acidophilus + Bifidobacterium Longum — 90 Billion CFU per capsule\u003c\/li\u003e\n\u003cli\u003eClinically validated formulation for uremic toxin elimination\u003c\/li\u003e\n\u003cli\u003eSupports pets suffering from Chronic Kidney Disease (CKD)\u003c\/li\u003e\n\u003cli\u003eSuitable for pets on dialysis as nutritional support\u003c\/li\u003e\n\u003cli\u003eEasy-to-administer capsule format\u003c\/li\u003e\n\u003cli\u003eSuitable for dogs and cats of all breeds\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eIndications\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eChronic Kidney Disease (CKD) in dogs and cats\u003c\/li\u003e\n\u003cli\u003ePets on dialysis requiring nutritional support\u003c\/li\u003e\n\u003cli\u003eElevated BUN\/creatinine levels and uremic toxin build-up\u003c\/li\u003e\n\u003cli\u003eGut microbiome restoration in renally compromised pets\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eDosage\u003c\/h3\u003e\u003cp\u003eOne capsule per day or as directed by a Registered Veterinary Practitioner.\u003c\/p\u003e\u003ch3\u003eStorage\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place away from direct sunlight. Keep refrigerated for extended shelf life. Keep out of reach of children.\u003c\/p\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"2 Strips","offer_id":47141854675119,"sku":null,"price":3798.0,"currency_code":"INR","in_stock":true},{"title":"3 Strips","offer_id":47141854707887,"sku":null,"price":5660.0,"currency_code":"INR","in_stock":true},{"title":"5 Strips","offer_id":47452444885167,"sku":null,"price":9206.0,"currency_code":"INR","in_stock":true},{"title":"6 Strips","offer_id":47454339170479,"sku":null,"price":10931.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/ChatGPT_Image_Sep_6_2026_01_09_10_PM.png?v=1788680386"},{"product_id":"enavant-k9pea-dog-supplement-for-dogs-cats","title":"Enavant K9PEA Palmitoylethanolamide Supplement for Dogs \u0026 Cats - Strip of 10 Tablets","description":"\u003cp\u003e\u003cstrong\u003eEnavant K9PEA\u003c\/strong\u003e is a patented veterinary supplement containing \u003cstrong\u003ePalmitoylethanolamide (PEA)\u003c\/strong\u003e, Genistein, and Daidzein. Specially formulated for dogs and cats suffering from chronic pain and dermatitis, K9PEA leverages PEA — an endogenous fatty acid amide produced in response to stress and tissue damage — to regulate chronic inflammation and pain at the receptor level.\u003c\/p\u003e\u003ch3\u003eKey Features\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eModulates \u003cstrong\u003ePPAR Alpha, CB1, and TRPV1 receptors\u003c\/strong\u003e for effective pain and inflammation control\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMast cell stabilization\u003c\/strong\u003e — controls excessive inflammation in chronic pain and dermatitis\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMicronized PEA\u003c\/strong\u003e with FAAH inhibitor for optimal absorption and bioavailability\u003c\/li\u003e\n\u003cli\u003eGenistein and Daidzein provide additional anti-inflammatory and antioxidant support\u003c\/li\u003e\n\u003cli\u003eNon-opioid, non-NSAID mechanism — safer for long-term use\u003c\/li\u003e\n\u003cli\u003eSuitable for dogs and cats of all breeds\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eIndications\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eChronic pain management in dogs and cats\u003c\/li\u003e\n\u003cli\u003eAtopic dermatitis and allergic skin conditions\u003c\/li\u003e\n\u003cli\u003eNeuropathic pain and nerve inflammation\u003c\/li\u003e\n\u003cli\u003ePost-operative pain support\u003c\/li\u003e\n\u003cli\u003eArthritis and musculoskeletal pain\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eDirections for Use\u003c\/h3\u003e\u003cp\u003eAdminister as directed by a Registered Veterinary Practitioner. Available in 1 Strip (10 tablets), 2 Strips (20 tablets), and 3 Strips (30 tablets).\u003c\/p\u003e\u003ch3\u003eStorage\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place away from direct sunlight. Keep out of reach of children.\u003c\/p\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"1 Strip","offer_id":47141942821039,"sku":null,"price":325.0,"currency_code":"INR","in_stock":true},{"title":"2 Strips","offer_id":47141942853807,"sku":null,"price":630.0,"currency_code":"INR","in_stock":true},{"title":"3 Strips","offer_id":47141942886575,"sku":null,"price":941.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/Untitleddesign-2026-07-04T170137.174.png?v=1783164945"},{"product_id":"enavant-avopea-pet-shampoo-200ml-for-dogs-cats-relieve-itch-repair-skin-barrier-radiant-coat-formula","title":"Enavant AVOPEA Pet Shampoo 200ml for Dogs \u0026 Cats","description":"\u003cp\u003e\u003cstrong\u003eEnavant AVOPEA Pet Shampoo 200ml\u003c\/strong\u003e is a premium veterinary-grade shampoo for dogs and cats, powered by a unique combination of \u003cstrong\u003ePEA (Palmitoylethanolamide)\u003c\/strong\u003e and Avocado extracts. Designed to Relieve, Repair, and Radiate — AVOPEA targets itchy, sensitive, and damaged skin while rebuilding the bio-identical skin barrier and restoring a vibrant, shiny coat.\u003c\/p\u003e\u003cp\u003eManufactured by Enavant Petcare. Creative visualization; actual product may vary.\u003c\/p\u003e\u003ch3\u003e3R Benefits\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelieve\u003c\/strong\u003e — Rapid itch and redness control for sensitive and allergy-prone pets\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRepair\u003c\/strong\u003e — Rebuilds the bio-identical skin barrier for long-lasting protection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRadiate\u003c\/strong\u003e — Restores coat vitality for a vibrant, healthy shine\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eKey Features\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003ePEA (Palmitoylethanolamide) — endocannabinoid system support for itch and inflammation control\u003c\/li\u003e\n\u003cli\u003eAvocado extract — rich in vitamins and fatty acids for deep nourishment\u003c\/li\u003e\n\u003cli\u003eSuitable for dogs and cats of all breeds and coat types\u003c\/li\u003e\n\u003cli\u003eGentle, pH-balanced formula for regular use\u003c\/li\u003e\n\u003cli\u003e200ml bottle — easy to use and store\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eIndications\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eAtopic dermatitis and allergic skin conditions\u003c\/li\u003e\n\u003cli\u003eItchy, dry, or sensitive skin\u003c\/li\u003e\n\u003cli\u003eDull, damaged, or shedding coat\u003c\/li\u003e\n\u003cli\u003eRoutine grooming and skin health maintenance\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eDirections for Use\u003c\/h3\u003e\u003cp\u003eWet the pet's coat thoroughly. Apply AVOPEA shampoo and lather gently. Leave for 3-5 minutes to allow active ingredients to work. Rinse thoroughly. Repeat if necessary. Use as directed by a veterinarian for best results.\u003c\/p\u003e\u003ch3\u003eStorage\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place away from direct sunlight. Keep out of reach of children.\u003c\/p\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"Default Title","offer_id":47421579985071,"sku":null,"price":669.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/Avopea_825-X-1032-px.jpg?v=1788164993"},{"product_id":"enavant-phoralk9-sevelamer-tablets-for-dogs-cats-phosphate-binder-for-ckd-10-x-15-tablets","title":"Enavant PHORALK9 Sevelamer Tablets for Dogs \u0026 Cats - 10 x 15 Tablets","description":"\u003cp\u003e\u003cstrong\u003eEnavant PHORALK9\u003c\/strong\u003e contains \u003cstrong\u003eSevelamer\u003c\/strong\u003e, a non-calcium, non-absorbed phosphate binder specially formulated for veterinary use in dogs and cats. Available in 400mg and 800mg strengths, PHORALK9 helps control elevated serum phosphorus levels in pets suffering from Chronic Kidney Disease (CKD), reducing the progression of renal damage and associated complications.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSchedule H Prescription Drug - Rx. Caution:\u003c\/strong\u003e Not to be sold by retail without the prescription of a Registered Veterinary Practitioner. For veterinary use only. Not for human use. Keep out of reach of children.\u003c\/p\u003e\u003ch3\u003eComposition\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003ePHORALK9-400: Sevelamer 400mg per tablet\u003c\/li\u003e\n\u003cli\u003ePHORALK9-800: Sevelamer 800mg per tablet\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eKey Features\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eNon-calcium phosphate binder — no risk of hypercalcemia\u003c\/li\u003e\n\u003cli\u003eBinds dietary phosphate in the GI tract, preventing absorption\u003c\/li\u003e\n\u003cli\u003eHelps maintain target serum phosphorus levels in CKD pets\u003c\/li\u003e\n\u003cli\u003eReduces progression of secondary hyperparathyroidism\u003c\/li\u003e\n\u003cli\u003eAvailable in two strengths for flexible dosing as per veterinarian guidance\u003c\/li\u003e\n\u003cli\u003ePack: 10 x 15 tablets (150 tablets per box)\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eIndications\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eHyperphosphatemia (elevated blood phosphorus) in dogs and cats\u003c\/li\u003e\n\u003cli\u003eChronic Kidney Disease (CKD) management\u003c\/li\u003e\n\u003cli\u003eSecondary hyperparathyroidism associated with CKD\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eDosage\u003c\/h3\u003e\u003cp\u003eAs directed by a Registered Veterinary Practitioner based on serum phosphorus levels and body weight.\u003c\/p\u003e\u003ch3\u003eStorage\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place away from direct sunlight. Keep out of reach of children.\u003c\/p\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"400 mg","offer_id":47421624254639,"sku":null,"price":349.0,"currency_code":"INR","in_stock":true},{"title":"800 mg","offer_id":47421624287407,"sku":null,"price":669.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/ChatGPT_Image_Aug_31_2026_02_23_36_PM.png?v=1788166572"},{"product_id":"enavant-sobirenk9-500mg-sodium-bicarbonate-tablets-for-dogs-cats-metabolic-acidosis-ckd-support-strip-of-10-tablets","title":"Enavant SOBIRENK9 500mg Sodium Bicarbonate Tablets for Dogs \u0026 Cats - Strip of 10 Tablets","description":"\u003cp\u003e\u003cstrong\u003eEnavant SOBIRENK9 500mg\u003c\/strong\u003e contains \u003cstrong\u003eSodium Bicarbonate 500mg\u003c\/strong\u003e per tablet, a veterinary supplement specifically formulated to help manage \u003cstrong\u003emetabolic acidosis\u003c\/strong\u003e in dogs and cats, commonly associated with Chronic Kidney Disease (CKD). By correcting acid-base imbalance, SOBIRENK9 supports kidney function, improves appetite, and enhances overall quality of life in renally compromised pets.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSchedule H Prescription Drug - Rx. Caution:\u003c\/strong\u003e Not to be sold by retail without the prescription of a Registered Veterinary Practitioner. For veterinary use only. Not for human use. Keep out of reach of children.\u003c\/p\u003e\u003ch3\u003eComposition\u003c\/h3\u003e\u003cp\u003eSodium Bicarbonate IP 500mg per tablet.\u003c\/p\u003e\u003ch3\u003eKey Features\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eCorrects metabolic acidosis — restores normal blood pH in CKD pets\u003c\/li\u003e\n\u003cli\u003eReduces acid load on compromised kidneys, slowing disease progression\u003c\/li\u003e\n\u003cli\u003eHelps improve appetite and energy levels in acidotic pets\u003c\/li\u003e\n\u003cli\u003eSupports muscle mass preservation by reducing protein catabolism\u003c\/li\u003e\n\u003cli\u003eEasy-to-administer tablet format\u003c\/li\u003e\n\u003cli\u003eSuitable for dogs and cats of all breeds\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eIndications\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eMetabolic acidosis associated with Chronic Kidney Disease (CKD)\u003c\/li\u003e\n\u003cli\u003eRenal tubular acidosis in dogs and cats\u003c\/li\u003e\n\u003cli\u003eSupportive therapy for renally compromised pets\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eDosage\u003c\/h3\u003e\u003cp\u003eAs directed by a Registered Veterinary Practitioner based on blood gas analysis and body weight.\u003c\/p\u003e\u003ch3\u003eStorage\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place away from direct sunlight. Keep out of reach of children.\u003c\/p\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"Default Title","offer_id":47421662003375,"sku":null,"price":63.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/ChatGPTImageAug31_2026_03_14_42PM.png?v=1788169511"},{"product_id":"enavant-udcak9-ursodeoxycholic-acid-tablets-for-dogs-cats-liver-support-bile-acid-therapy-10-x-15-tablets","title":"Enavant UDCAK9 Ursodeoxycholic Acid Tablets for Dogs \u0026 Cats - 10 x 15 Tablets","description":"\u003cp\u003e\u003cstrong\u003eSCHEDULE H PRESCRIPTION VETERINARY MEDICINE — Not to be sold by retail without the prescription of a Registered Veterinary Practitioner. For veterinary use only. Not for human use. UDCA is contraindicated in complete biliary obstruction — confirm biliary patency (bile duct obstruction must be excluded by abdominal ultrasound) before initiating therapy; in complete extrahepatic bile duct obstruction, UDCA cannot be excreted and accumulates as a toxic bile acid load. Use with caution in cats with suspected bile duct obstruction secondary to pancreatitis (triaditis: concurrent pancreatitis, cholangiohepatitis, and IBD). Do not use in animals with known hypersensitivity to bile acids. Monitor liver enzymes (ALT, ALP, GGT, total bilirubin), bile acids, and albumin at baseline, 4 weeks, and every 3 months during long-term therapy. Keep out of reach of children. Store in a cool, dry place away from direct sunlight.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eEnavant UDCAK9 Ursodeoxycholic Acid (UDCA IP) Tablets for Dogs \u0026amp; Cats | Liver Support \u0026amp; Bile Acid Therapy | 150mg \u0026amp; 300mg | 10 x 15 Tablets (150 Tablets per Box)\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003eEnavant UDCAK9 is a Schedule H prescription veterinary hepatoprotective containing Ursodeoxycholic Acid IP (UDCA — also known as Ursodiol) in 150mg and 300mg tablet strengths for dogs and cats. UDCA is a naturally occurring tertiary bile acid (constituting only 1–3% of the normal human and canine bile acid pool, but elevated to 40–60% of the total bile acid pool during therapeutic supplementation) that exerts multiple hepatoprotective mechanisms: it replaces toxic hydrophobic bile acids in the bile acid pool with a hydrophilic, non-cytotoxic species; stabilises hepatocyte and cholangiocyte plasma membranes against hydrophobic bile acid-induced detergent disruption; protects mitochondria from bile acid-induced permeability transition pore opening and cytochrome c release; suppresses hepatocyte apoptosis via multiple anti-apoptotic signalling pathways; exerts immunomodulatory activity reducing inflammatory cytokine production and MHC class I aberrant expression on hepatocytes; and stimulates vesicular choleresis improving bile flow and reducing bile stasis. UDCAK9 is indicated for chronic hepatitis, cholangiohepatitis, intrahepatic cholestasis, gallbladder mucocele, and hepatic lipidosis in dogs and cats. Use under veterinary prescription with monitoring of liver function parameters.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eActive Ingredient \u0026amp; Mechanisms of Action\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\u003cli\u003e\n\u003cstrong\u003eUrsodeoxycholic Acid (UDCA) IP — Hydrophilic tertiary bile acid with hepatoprotective, choleretic, immunomodulatory, anti-apoptotic, and antifibrotic mechanisms:\u003c\/strong\u003e UDCA (3α,7β-dihydroxy-5β-cholan-24-oic acid — the 7β-epimer of chenodeoxycholic acid\/CDCA; the β-oriented 7-OH group vs the α-orientation of CDCA confers UDCA its hydrophilicity and distinguishes it from the cytotoxic 7α-OH-bearing primary and secondary bile acids) is a naturally occurring bile acid produced in small quantities by intestinal bacterial 7β-epimerisation of chenodeoxycholic acid; the liver disease state in dogs and cats is characterised by accumulation of toxic hydrophobic bile acids (chenodeoxycholic acid — CDCA, deoxycholic acid — DCA, lithocholic acid — LCA) that cause progressive hepatocyte and cholangiocyte injury via multiple mechanisms: UDCA therapy enriches the bile acid pool with a hydrophilic, low-toxicity species, displacing and diluting the toxic hydrophobic bile acids; mechanisms in detail:\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e(1) Bile acid pool hydrophilicity shift — dilution and displacement of toxic hydrophobic bile acids:\u003c\/strong\u003e oral UDCA is absorbed in the terminal ileum (via the apical sodium-dependent bile acid transporter — ASBT\/SLC10A2 — which co-transports bile acids with 2 Na+ ions driven by the Na+ electrochemical gradient maintained by the basolateral Na+\/K+-ATPase), transported to the liver via the portal vein bound to albumin and lipoproteins, taken up by hepatocytes via the sinusoidal Na+\/taurocholate cotransporting polypeptide (NTCP\/SLC10A1) and organic anion transporting polypeptides (OATPs), conjugated with taurine or glycine (dogs predominantly use taurine conjugation — tauroursodeoxycholic acid TUDC; cats, which have limited taurine synthesis, also rely on TUDCA conjugation — note the importance of ensuring adequate taurine intake in cats on restricted-protein diets), and excreted into bile via the canalicular bile salt export pump (BSEP\/ABCB11); during long-term UDCA therapy, UDCA constitutes 40–60% of the total bile acid pool, displacing hydrophobic toxic species; UDCA’s high hydrophilicity (lowest hydrophobicity index in the primary-secondary-tertiary bile acid series) means it does not disrupt phospholipid bilayer integrity, does not form mixed micelles with cytotoxic efficiency, and does not activate the hepatocyte plasma membrane Fas death receptor complex (see apoptosis section)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e(2) Membrane stabilisation of hepatocytes and cholangiocytes against hydrophobic bile acid-induced detergent disruption:\u003c\/strong\u003e hydrophobic bile acids (CDCA, DCA, LCA) intercalate into the hepatocyte plasma membrane phospholipid bilayer (they are amphipathic detergents that partition into biological membranes at micellar concentrations) → increase membrane fluidity → activate membrane receptor signalling cascades (EGFR, Src kinase, PI3K) inappropriately → disturb mitochondrial membrane integrity and promote mitochondrial reactive oxygen species (mtROS) generation; UDCA, due to its hydrophilic character, does not partition into membranes at therapeutic concentrations and instead competes with hydrophobic bile acids for membrane intercalation sites, protecting membrane structural integrity; additionally, UDCA stimulates the insertion of phosphatidylcholine (PC) into the canalicular membrane — PC forms a protective coating over the canalicular membrane that prevents bile acid-induced membrane damage (the phosphatidylcholine flippase MDR3\/ABCB4 translocates PC from the inner to the outer canalicular membrane leaflet — deficiency of MDR3\/ABCB4 causes progressive familial intrahepatic cholestasis type 3 — PFIC3 in humans); UDCA upregulates MDR3\/ABCB4 expression, enhancing biliary PC secretion and canalicular membrane protection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e(3) Mitochondrial protection — prevention of the mitochondrial permeability transition (MPT):\u003c\/strong\u003e toxic hydrophobic bile acids (particularly CDCA and LCA) enter hepatocyte mitochondria (their amphipathic structure allows membrane partitioning) and open the mitochondrial permeability transition pore (mPTP — a multiprotein complex at the inner mitochondrial membrane contact site, classically described as involving the voltage-dependent anion channel — VDAC — on the outer membrane, the adenine nucleotide translocator — ANT — on the inner membrane, and cyclophilin D — CypD — in the matrix; VDAC and ANT form the mPTP channel pore while CypD is the peptidyl-prolyl isomerase regulatory protein that binds the ANT and lowers the Ca2+ threshold for pore opening; note: the exact molecular composition of the mPTP remains partially uncertain with recent evidence questioning the classical VDAC\/ANT\/CypD model and implicating the ATP synthase\/F1F0-ATPase dimers as the pore-forming component); mPTP opening → mitochondrial inner membrane permeabilisation → dissipation of the mitochondrial membrane potential (ΔΨm) → uncoupling of oxidative phosphorylation (ATP synthesis collapses — energy failure) → mitochondrial swelling → outer mitochondrial membrane (OMM) rupture → release of pro-apoptotic proteins from the mitochondrial intermembrane space (IMS): cytochrome c (activates the intrinsic apoptosis pathway by forming the apoptosome — cytochrome c \/ Apaf-1 \/ procaspase-9 heptamer → caspase-9 activation → caspase-3\/7 executioner caspase activation), Smac\/DIABLO (neutralises XIAP — the X-linked inhibitor of apoptosis protein), and AIF (apoptosis-inducing factor — caspase-independent nuclear chromatin condensation); UDCA prevents bile acid-induced mPTP opening by: (a) activating the prosurvival PI3K\/Akt (protein kinase B) → phosphorylation and inactivation of the pro-apoptotic Bcl-2 family member BAD (Bcl-2-associated death promoter) → BAD cannot displace Bcl-2\/Bcl-xL from VDAC\/Bax, preventing MOMP; (b) activating Akt-mediated phosphorylation and nuclear exclusion of FOXO transcription factors → reduced expression of pro-apoptotic Bcl-2 family members (Bim, PUMA); (c) direct interaction with the inner mitochondrial membrane reducing CypD-mediated sensitisation to Ca2+-triggered pore opening\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e(4) Extrinsic apoptosis pathway inhibition — displacement of death receptors from the plasma membrane DISC:\u003c\/strong\u003e toxic hydrophobic bile acids activate the extrinsic (death receptor) apoptosis pathway in hepatocytes by: (a) clustering and activating the Fas death receptor (CD95\/FasR — a type I transmembrane protein of the TNFR superfamily) in the plasma membrane — hydrophobic bile acids increase membrane Fas receptor density and promote ligand-independent Fas oligomerisation → DISC (death-inducing signalling complex) formation → FADD recruitment → procaspase-8 activation → caspase-8 → Bid cleavage to tBid → tBid → mitochondria amplification loop (connecting extrinsic to intrinsic pathway) → caspase-3\/7 executioner activation; (b) upregulating DR5 (death receptor 5 — the TRAIL receptor) cell surface expression → TRAIL-mediated apoptosis of bile acid-stressed hepatocytes; UDCA’s membrane-stabilising effect prevents the membrane microdomain (lipid raft) reorganisation that drives Fas\/DR5 clustering, reducing ligand-independent death receptor activation in cholestatic hepatocytes; UDCA also stabilises the mitochondrial membrane against tBid-mediated MOMP, reducing cross-talk amplification from the extrinsic to intrinsic pathway\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e(5) Immunomodulatory effects — reduction of MHC class I aberrant hepatocyte expression and inflammatory cytokine suppression:\u003c\/strong\u003e in chronic hepatitis and cholangiohepatitis in dogs and cats, aberrant MHC (major histocompatibility complex) class I overexpression on hepatocytes renders them targets for cytotoxic T-lymphocyte (CTL)-mediated autoimmune attack (CD8+ CTLs recognise viral or auto-antigenic peptides presented by MHC class I on hepatocytes → perforin\/granzyme B-mediated hepatocyte lysis); hydrophobic bile acid accumulation upregulates hepatocyte MHC class I expression via NF-κB activation and IFN-γ signalling upregulation; UDCA reduces aberrant MHC class I hepatocyte expression by: suppressing NF-κB p65 nuclear translocation (via IκBα stabilisation) → reduced IL-1β, IL-6, TNF-α, and COX-2 expression; reducing IFN-γ receptor signalling → STAT1 activation reduced → MHC class I gene transcription downregulated; additionally, UDCA activates the glucocorticoid receptor (GR) via a non-genomic mechanism → GR-mediated NF-κB transrepression; the immunomodulatory effects of UDCA are particularly relevant in immune-mediated chronic hepatitis (lymphocytic\/lymphoplasmacytic hepatitis in dogs) and feline lymphocytic cholangiohepatitis\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e(6) Choleresis stimulation — bicarbonate-rich hypercholeresis and vesicular choleresis:\u003c\/strong\u003e UDCA stimulates bile flow (choleresis) by two mechanisms: (a) bicarbonate-stimulated hypercholeresis — UDCA (particularly TUDC — the taurine conjugate) activates a Cl−\/HCO3− exchanger (AE2 — SLC4A2) on the canalicular and ductular membrane via a Gs-protein\/cAMP\/PKA-mediated pathway and activation of the Cl− channel CFTR (cystic fibrosis transmembrane conductance regulator) → HCO3− secretion into the bile canaliculus → alkalinisation of the bile acid microenvironment at the canalicular membrane → protonation of anionic bile acids reduced (maintains bile acids in their ionised, membrane-impermeant form → reduces retrograde permeation of bile acids through canalicular and ductular epithelium — the ‘biliary bicarbonate umbrella’ hypothesis); (b) vesicular choleresis — UDCA promotes exocytosis of vesicles from the trans-Golgi network (TGN) containing BSEP\/ABCB11 transporters to the canalicular membrane, increasing the density of bile acid export pumps on the canalicular surface → enhanced bile acid secretory capacity; this is mediated via a α-PKC-dependent signalling cascade involving UDCA activation of the EGF receptor transactivation pathway\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e(7) Antifibrotic effects:\u003c\/strong\u003e hepatic stellate cells (HSCs — perisinusoidal Ito cells) are the primary collagen-secreting cells responsible for hepatic fibrosis; in chronic liver injury, HSCs are activated from their quiescent lipocyte state to an activated myofibroblast-like state (expressing α-SMA — alpha-smooth muscle actin) by TGF-β1 (transforming growth factor β1 — the principal pro-fibrogenic cytokine), PDGF-BB (platelet-derived growth factor BB — the primary HSC mitogen and chemoattractant), and reactive oxygen species; activated HSCs secrete type I and III collagen, fibronectin, and tissue inhibitor of metalloproteinases (TIMPs — which inhibit matrix metalloproteinases — MMPs — that normally degrade fibrillar collagen) → progressive periportal and perisinusoidal fibrosis → cirrhosis; UDCA reduces HSC activation by: reducing hydrophobic bile acid load (the primary trigger for Kupffer cell and stellate cell activation in cholestatic liver disease), suppressing TGF-β1 production from injured hepatocytes, and reducing ROS production from mitochondria-stressed hepatocytes that would otherwise paracrinally activate adjacent HSCs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eIndications\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic hepatitis (lymphocytic\/lymphoplasmacytic hepatitis in dogs):\u003c\/strong\u003e the most common inflammatory liver disease in dogs; immune-mediated CD3+ T-lymphocyte and plasma cell infiltration of portal and periportal regions with hepatocyte apoptosis and progressive fibrosis; UDCA reduces hepatocyte MHC class I expression, suppresses inflammatory cytokine production, and protects against hydrophobic bile acid-augmented hepatocyte apoptosis\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFeline cholangiohepatitis (cholangitis):\u003c\/strong\u003e the most common hepatobiliary disorder in cats; classified as neutrophilic (acute — associated with ascending bacterial infection from the duodenum via the common bile duct, which in cats opens into the duodenum adjacent to the pancreatic duct, facilitating ascending infection and triaditis) and lymphocytic (chronic — immune-mediated); UDCA provides anti-inflammatory and hepatoprotective support; concurrent antibiotic therapy (amoxicillin-clavulanate, metronidazole) is typically required for neutrophilic cholangiohepatitis\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntrahepatic cholestasis:\u003c\/strong\u003e impaired bile flow within the liver (canalicular cholestasis) causing accumulation of toxic bile acids, bilirubin, and other biliary constituents within hepatocytes and bile canaliculi; causes in dogs and cats include: hepatocellular disease (hepatitis, hepatic lipidosis, drug-induced liver injury), cholangitis, and primary biliary disorders; UDCA’s choleretic and hepatoprotective mechanisms directly address the pathophysiology\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGallbladder mucocele (dogs):\u003c\/strong\u003e abnormal accumulation of inspissated mucus within the gallbladder lumen forming a characteristic kiwi-fruit stellate pattern on ultrasound; associated with hypothyroidism, hyperlipidaemia (Shetland Sheepdog, Cocker Spaniel predisposition), and steroid hepatopathy; UDCA improves bile flow and reduces bile viscosity, potentially slowing mucocele progression; surgical cholecystectomy is indicated for rupture or severe cases\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatic lipidosis (feline idiopathic hepatic lipidosis — FIHL):\u003c\/strong\u003e the most common severe liver disease in cats; occurs after any period of anorexia (≥3–5 days) in overweight cats → peripheral lipolysis → massive hepatic fatty acid delivery → exceeds hepatic β-oxidation and VLDL export capacity → triglyceride accumulation in hepatocytes (\u0026gt;50% hepatocytes with lipid vacuoles on histology) → hepatocellular dysfunction and intrahepatic cholestasis; UDCA reduces secondary bile acid-mediated cholestatic injury in FIHL; primary treatment is aggressive nutritional support via oesophagostomy or gastrostomy tube feeding\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePortosystemic shunts (PSS) — supportive therapy:\u003c\/strong\u003e congenital or acquired PSS divert portal blood (containing enteric toxins, bile acids, and ammonia) directly to systemic circulation bypassing hepatic detoxification → hepatic encephalopathy, hyperammonaemia, and bile acid accumulation; UDCA provides hepatoprotective support; definitive treatment is surgical ligation or ameroid constrictor placement\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic copper-associated hepatopathy (copper storage disease in Bedlington Terriers, Labrador Retrievers, Dalmatians, West Highland White Terriers):\u003c\/strong\u003e UDCA may provide adjunctive hepatoprotection alongside copper chelation therapy (d-penicillamine) and copper-restricted diet\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eDosage \u0026amp; Administration\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eAs directed by a Registered Veterinary Practitioner based on body weight and liver function test results\u003c\/li\u003e\n\u003cli\u003eTypical dose range: 10–15 mg\/kg orally once daily with food (food improves UDCA absorption via stimulation of biliary secretion and mixed micelle formation enhancing intestinal UDCA solubilisation)\u003c\/li\u003e\n\u003cli\u003e150mg tablets: suitable for smaller dogs and cats (approximately 10–15kg at standard dose)\u003c\/li\u003e\n\u003cli\u003e300mg tablets: suitable for medium-to-large dogs (approximately 20–30kg at standard dose)\u003c\/li\u003e\n\u003cli\u003eLong-term therapy is typically required for chronic liver disease — do not discontinue without veterinary guidance\u003c\/li\u003e\n\u003cli\u003eMonitor liver enzymes (ALT, ALP, GGT), total bilirubin, albumin, bile acids, and body weight at baseline, 4 weeks after initiation, and every 3 months during maintenance therapy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eSafety Information\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eContraindicated in complete biliary obstruction — confirm biliary patency by abdominal ultrasound before initiation\u003c\/li\u003e\n\u003cli\u003eUse with caution in feline triaditis (concurrent pancreatitis + cholangiohepatitis + IBD) — confirm bile duct patency\u003c\/li\u003e\n\u003cli\u003eStore in a cool, dry place away from direct sunlight; keep out of reach of children\u003c\/li\u003e\n\u003cli\u003eSchedule H prescription drug — veterinary prescription mandatory\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\u003c\/ul\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"150mg","offer_id":47421694967983,"sku":null,"price":329.0,"currency_code":"INR","in_stock":true},{"title":"300mg","offer_id":47421695000751,"sku":null,"price":633.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/ChatGPT_Image_Aug_31_2026_03_37_45_PM.png?v=1788171396"},{"product_id":"enavant-ximsibo-rifaximin-tablets-for-dogs-gut-antibiotic-for-sibo-he-travellers-diarrhoea-10-x-10-tablets","title":"Enavant XIMSIBO Rifaximin Tablets for Dogs - 10 x 10 Tablets","description":"\u003cp\u003e\u003cstrong\u003eEnavant XIMSIBO\u003c\/strong\u003e contains \u003cstrong\u003eRifaximin IP\u003c\/strong\u003e, a minimally absorbed, gut-selective antibiotic specifically formulated for use in dogs. Available in 200mg and 400mg strengths, XIMSIBO targets pathogenic gut bacteria responsible for Small Intestinal Bacterial Overgrowth (SIBO), Hepatic Encephalopathy (HE), and acute infective diarrhoea, with minimal systemic absorption ensuring high local concentration and reduced risk of systemic side effects.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eRx. Schedule H Prescription Drug - Caution:\u003c\/strong\u003e Not to be sold by retail without the prescription of a Registered Veterinary Practitioner. For use in dogs only. Not for human use. Keep out of reach of children.\u003c\/p\u003e\u003ch3\u003eComposition\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eXIMSIBO-200: Rifaximin IP 200mg per tablet\u003c\/li\u003e\n\u003cli\u003eXIMSIBO-400: Rifaximin IP 400mg per tablet\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eKey Features\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eGut-selective antibiotic — acts locally in the GI tract with minimal systemic absorption\u003c\/li\u003e\n\u003cli\u003eBroad-spectrum activity against gram-positive and gram-negative gut pathogens\u003c\/li\u003e\n\u003cli\u003eReduces ammonia-producing bacteria — key mechanism in managing Hepatic Encephalopathy\u003c\/li\u003e\n\u003cli\u003eHelps restore normal gut flora balance in SIBO\u003c\/li\u003e\n\u003cli\u003eLow risk of systemic side effects compared to conventional antibiotics\u003c\/li\u003e\n\u003cli\u003eAvailable in two strengths for weight-based dosing flexibility\u003c\/li\u003e\n\u003cli\u003ePack: 10 x 10 tablets (100 tablets per box)\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eIndications\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eSmall Intestinal Bacterial Overgrowth (SIBO) in dogs\u003c\/li\u003e\n\u003cli\u003eHepatic Encephalopathy (HE) — reduction of ammonia-producing gut bacteria\u003c\/li\u003e\n\u003cli\u003eAcute infective and traveller’s diarrhoea\u003c\/li\u003e\n\u003cli\u003eIrritable Bowel Syndrome (IBS) with gut dysbiosis\u003c\/li\u003e\n\u003cli\u003ePost-antibiotic gut flora restoration\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eDosage\u003c\/h3\u003e\u003cp\u003eAs directed by a Registered Veterinary Practitioner based on body weight, indication, and duration of therapy.\u003c\/p\u003e\u003ch3\u003eStorage\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place away from direct sunlight. Keep out of reach of children.\u003c\/p\u003e","brand":"Paws \u0026 Tails™","offers":[{"title":"200mg","offer_id":47422552244399,"sku":null,"price":169.0,"currency_code":"INR","in_stock":true},{"title":"400mg","offer_id":47422552277167,"sku":null,"price":349.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0729\/0316\/4079\/files\/ChatGPT_Image_Aug_31_2026_05_14_44_PM.png?v=1788176997"}],"url":"https:\/\/sg37v1-ta.myshopify.com\/collections\/enavant.oembed","provider":"Paws \u0026 Tails™","version":"1.0","type":"link"}